Loertscher R
Department of Medicine, Royal Victoria Hospital, Montreal, Quebec, Canada.
Transplant Proc. 1988 Dec;20(6):1258-9.
In vitro activated suppressor cells were tested for their ability to inhibit TFR expression. Interleukin 2 receptors and TFR are similarly suppressed on both CD4+ and CD8+ T cells. Addition of exogenous rIL2 permits appearance of IL2R but not TFR on CD4+ and CD8+ T cells. In the presence of rIL2, however, the percentage of CD4+ T cells is significantly diminished, while Leu11-positive natural killer cells escape the regulatory effect of Ts.